Pfizer, Inc. (PFE) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Pfizer, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.076 Good day, everyone, and welcome to Pfizer's second quarter 2025 earnings conference 00:00:05.076 -- 00:00:09.261 call. Today's call is being recorded. 00:00:09.261 -- 00:00:13.626 At this time, I would like to turn the call over to Francesca DiMartino, Chief Investor 00:00:13.626 -- 00:00:16.609 Relations Officer and Senior Vice President. 00:00:16.609 -- 00:00:19.290 Please go ahead, ma'am. 00:00:24.117 -- 00:00:26.680 Good morning, and welcome to Pfizer's earnings call. 00:00:26.680 -- 00:00:30.153 I'm Francesca DiMartino, Chief Investor Relations Officer. 00:00:30.153 -- 00:00:33.097 On behalf of the Pfizer team, thank you for joining us. 00:00:33.097 -- 00:00:37.662 This call is being made available via audio webcast at Pfizer.com. 00:00:37.662 -- 00:00:42.368 Earlier this morning, we released our results for the second quarter of 2025 via a press 00:00:42.368 -- 00:00:46.413 release that is available on our website at Pfizer.com. 00:00:46.413 -- 00:00:52.680 I'm joined today by Dr. Albert Bourla, our chairman and CEO, and Dave Denton, our CFO. 00:00:52.680 -- 00:00:57.035 Albert and Dave have some prepared remarks, and we will then open the call for questions. 00:00:57.035 -- 00:01:01.141 Members of our leadership team will be available for the Q&A session. 00:01:01.141 -- 00:01:05.086 Before we get started, I want to remind you that we will be making forward-looking statements 00:01:05.086 -- 00:01:08.330 and discussing certain non-GAAP financial measures. 00:01:08.330 -- 00:01:12.055 I encourage you to read the disclaimers in our slide presentation, the press release 00:01:12.055 -- 00:01:16.862 we issued this morning, and the disclosures in our SEC filings, which are all available 00:01:16.862 -- 00:01:20.018 on the IR webs...